Get the Stockscreener App
1.38
0.00%
0.00
After Hours:
1.38
Aytu Biopharma Inc Stock (AYTU) Forecast
The Aytu Biopharma Inc (AYTU) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $201.43, representing a +14,497% increase from the current price of $1.38. The highest analyst price target is $204.66, and the lowest is $198.21.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AYTU Price Target
Average 143.01
(+10,263% Upside)
Is Aytu Biopharma Inc (AYTU) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.72 | Neutral |
| STOCH(9,6) | 12.74 | Buy |
| STOCHRSI(14) | 20.95 | Neutral |
| MACD(12,26) | -0.1069 | Sell |
| ADX(14) | 23.06 | Neutral |
| William %R | -82.20 | Buy |
| CCI(14) | -96.18 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.4775
Sell
|
1.4507
Sell
|
| MA20 |
1.5415
Sell
|
1.5285
Sell
|
| MA50 |
1.778
Sell
|
1.7547
Sell
|
| MA100 |
2.1193
Sell
|
2.0357
Sell
|
| MA200 |
2.543
Sell
|
2.2781
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, AYTU could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AYTU, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.72 indicates that AYTU is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.74 indicates that AYTU is oversold. This indicates that AYTU price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.95 indicates that AYTU is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.06 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -96.18 indicates that AYTU is still oversold but not to an extreme extent.
Long-term AYTU price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aytu Biopharma Inc financial reports and earnings history, Aytu Biopharma Inc (AYTU) stock could reach $506.34 by 2030, $295.56 by 2040 and $960.85 by 2050. See the projected annual prices until 2050 of the Aytu Biopharma Inc stock below:
- Aytu Biopharma Inc (AYTU) is expected to reach an average price of $86.34 in 2035, with a high prediction of $97.93 and a low estimate of $86.60. This indicates an $6,157% rise from the last recorded price of $1.38.
- Aytu Biopharma Inc (AYTU) stock is projected to chart a bullish course in 2040, with an average price target of $282.26, representing an $20,353% surge from its current level. The forecast ranges from a conservative $282.41 to a sky-high $295.56.
- Our analysts predict Aytu Biopharma Inc (AYTU) to jump 41,341% by 2045, soaring from $572.03 to an average price of $571.88, potentially reaching $588.54. While $572.03 is the low estimate, the potential upside is significant.
- Aytu Biopharma Inc (AYTU) stock is expected to climb by 2050, reaching an average of $940.79, a $68,073% jump from its current level. However, a wide range of estimates exists, with high and low targets of $960.85 and $942.79, respectively, highlighting the market's uncertainty.
Aytu Biopharma Inc Stock (AYTU) Year by Year Forecast
Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2025
Aytu Biopharma Inc Stock (AYTU) is expected to reach an average price of $143.01 in 2025, with a high prediction of $235.37 and a low estimate of $50.66. This indicates an +10,263% rise from the last recorded price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $182.72 | $198.21 | $204.66 | +13,141% |
| February, 2025 | $232.19 | $227.76 | $205.19 | +16,725% |
| March, 2025 | $264.85 | $236.30 | $218.85 | +19,092% |
| April, 2025 | $63.43 | $54.92 | $235.37 | +4,497% |
| May, 2025 | $79.50 | $81.50 | $57.50 | +5,661% |
| June, 2025 | $39.56 | $51.56 | $69.99 | +2,767% |
| July, 2025 | $40.14 | $62.14 | $47.63 | +2,809% |
| August, 2025 | $64.21 | $50.66 | $55.69 | +4,553% |
| September, 2025 | $56.27 | $58.27 | $42.27 | +3,978% |
| October, 2025 | $128.66 | $75.31 | $99.34 | +9,223% |
| November, 2025 | $80.92 | $92.40 | $89.37 | +5,764% |
| December, 2025 | $121.44 | $83.44 | $107.50 | +8,700% |
Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2026
The predicted value for Aytu Biopharma Inc (AYTU) in 2026 is set at an average of $141.54. Estimates vary from a peak of $173.93 to a trough of $109.14, indicating an +10,156% surge from the present price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $121.61 | $122.53 | $116.87 | +8,712% |
| February, 2026 | $177.43 | $128.88 | $164.43 | +12,757% |
| March, 2026 | $144.90 | $160.70 | $170.15 | +10,400% |
| April, 2026 | $124.88 | $127.08 | $124.81 | +8,949% |
| May, 2026 | $85.74 | $109.14 | $121.51 | +6,113% |
| June, 2026 | $129.81 | $129.29 | $123.41 | +9,306% |
| July, 2026 | $159.29 | $139.84 | $150.49 | +11,443% |
| August, 2026 | $152.25 | $156.85 | $155.54 | +10,933% |
| September, 2026 | $157.83 | $154.69 | $154.63 | +11,337% |
| October, 2026 | $169.70 | $167.95 | $166.70 | +12,197% |
| November, 2026 | $165.76 | $169.76 | $173.93 | +11,912% |
| December, 2026 | $176.74 | $167.68 | $173.43 | +12,708% |
Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aytu Biopharma Inc (AYTU) is $165.18, with a high forecast of $181.69 and a low forecast of $148.67. This indicates an +11,870% increase from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $179.21 | $175.86 | $175.01 | +12,886% |
| February, 2027 | $182.07 | $175.44 | $174.93 | +13,094% |
| March, 2027 | $183.06 | $182.11 | $179.46 | +13,165% |
| April, 2027 | $182.12 | $182.92 | $181.69 | +13,097% |
| May, 2027 | $177.59 | $178.99 | $180.92 | +12,768% |
| June, 2027 | $172.77 | $172.77 | $173.56 | +12,419% |
| July, 2027 | $168.23 | $168.43 | $170.28 | +12,091% |
| August, 2027 | $171.08 | $167.15 | $165.95 | +12,297% |
| September, 2027 | $165.04 | $165.68 | $168.64 | +11,859% |
| October, 2027 | $160.54 | $161.32 | $163.39 | +11,533% |
| November, 2027 | $150.85 | $152.19 | $157.61 | +10,831% |
| December, 2027 | $151.40 | $148.67 | $149.12 | +10,871% |
Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2028
In 2028, Aytu Biopharma Inc (AYTU) is projected to reach an average price of $114.28, with a high projection of $149.90 and a low estimate of $78.65. This indicates an +8,181% rise from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $146.67 | $146.87 | $149.90 | +10,528% |
| February, 2028 | $141.62 | $141.72 | $145.18 | +10,162% |
| March, 2028 | $134.62 | $134.70 | $139.48 | +9,655% |
| April, 2028 | $128.17 | $128.39 | $132.97 | +9,188% |
| May, 2028 | $120.74 | $120.74 | $126.08 | +8,650% |
| June, 2028 | $115.07 | $115.20 | $119.11 | +8,238% |
| July, 2028 | $109.45 | $109.48 | $113.48 | +7,831% |
| August, 2028 | $102.92 | $103.01 | $107.94 | +7,358% |
| September, 2028 | $97.11 | $97.18 | $101.19 | +6,937% |
| October, 2028 | $91.86 | $91.99 | $95.22 | +6,556% |
| November, 2028 | $84.15 | $84.32 | $89.66 | +5,998% |
| December, 2028 | $78.43 | $78.65 | $82.65 | +5,583% |
Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2029
The 2029 price forecast for Aytu Biopharma Inc Stock (AYTU) is $199.86 on average, with a high prediction of $398.21 and a low estimate of $1.5079. This represents an +14,383% increase from the previous price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $70.80 | $70.93 | $76.77 | +5,031% |
| February, 2029 | $64.94 | $65.03 | $69.28 | +4,606% |
| March, 2029 | $59.12 | $59.22 | $63.42 | +4,184% |
| April, 2029 | $51.82 | $52.21 | $57.58 | +3,655% |
| May, 2029 | $44.48 | $44.58 | $49.82 | +3,123% |
| June, 2029 | $39.11 | $39.19 | $42.85 | +2,734% |
| July, 2029 | $32.68 | $32.82 | $37.45 | +2,268% |
| August, 2029 | $25.37 | $25.37 | $31.10 | +1,738% |
| September, 2029 | $19.23 | $19.35 | $23.91 | +1,294% |
| October, 2029 | $11.70 | $11.92 | $17.68 | +748.15% |
| November, 2029 | $6.0193 | $6.1593 | $10.09 | +336.18% |
| December, 2029 | $436.21 | $1.5079 | $398.21 | +31,510% |
Aytu Biopharma Inc Stock (AYTU) Price Forecast for 2030
Aytu Biopharma Inc Stock (AYTU) is expected to reach an average price of $518.13 in 2030, with a high forecast of $616.42 and a low forecast of $419.84. This signifies an +37,445% surge from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $516.38 | $517.25 | $506.34 | +37,319% |
| February, 2030 | $495.51 | $492.47 | $470.41 | +35,806% |
| March, 2030 | $561.64 | $522.54 | $509.24 | +40,598% |
| April, 2030 | $548.81 | $566.73 | $546.67 | +39,668% |
| May, 2030 | $570.93 | $548.86 | $556.95 | +41,272% |
| June, 2030 | $577.06 | $578.02 | $551.96 | +41,716% |
| July, 2030 | $642.22 | $593.12 | $616.42 | +46,438% |
| August, 2030 | $603.31 | $624.35 | $611.25 | +43,618% |
| September, 2030 | $603.46 | $582.41 | $559.70 | +43,629% |
| October, 2030 | $589.46 | $607.51 | $593.65 | +42,615% |
| November, 2030 | $505.77 | $641.69 | $604.74 | +36,550% |
| December, 2030 | $399.90 | $419.84 | $383.90 | +28,878% |
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):